221 related articles for article (PubMed ID: 12688326)
1. Non-cytotoxic gamma-delta peripheral T-cell lymphoma affecting the mandibular and parotidal lymph nodes and the skin.
Lima M; Canelhas A; Santos C; dos Anjos Teixeira M; Coutinho J; Alves R; Queirós ML; Fonseca S; Santos AH; Gonçalves V; Massa A; Justiça B
Leuk Lymphoma; 2003 Mar; 44(3):525-9. PubMed ID: 12688326
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
4. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.
Ohshima K; Haraoka S; Harada N; Kamimura T; Suzumiya J; Kanda M; Kawasaki C; Sugihara M; Kikuchi M
Histopathology; 2000 Feb; 36(2):127-35. PubMed ID: 10672057
[TBL] [Abstract][Full Text] [Related]
5. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
[TBL] [Abstract][Full Text] [Related]
6. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
[TBL] [Abstract][Full Text] [Related]
7. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.
Salhany KE; Feldman M; Kahn MJ; Peritt D; Schretzenmair RD; Wilson DM; DiPaola RS; Glick AD; Kant JA; Nowell PC; Kamoun M
Hum Pathol; 1997 Jun; 28(6):674-85. PubMed ID: 9191001
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.
Katoh A; Ohshima K; Kanda M; Haraoka S; Sugihara M; Suzumiya J; Kawasaki C; Shimazaki K; Ikeda S; Kikuchi M
Leuk Lymphoma; 2000 Sep; 39(1-2):97-111. PubMed ID: 10975388
[TBL] [Abstract][Full Text] [Related]
9. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
Pan ST; Chang WS; Murphy M; Martinez A; Chuang SS
Am J Dermatopathol; 2011 Apr; 33(2):e17-20. PubMed ID: 21252637
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.
Kumar S; Krenacs L; Medeiros J; Elenitoba-Johnson KS; Greiner TC; Sorbara L; Kingma DW; Raffeld M; Jaffe ES
Hum Pathol; 1998 Apr; 29(4):397-403. PubMed ID: 9563791
[TBL] [Abstract][Full Text] [Related]
12. Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entity.
Mukai HY; Hasegawa Y; Kojima H; Okoshi Y; Takei N; Yamashita Y; Nagasawa T; Mori N
Mod Pathol; 2002 Nov; 15(11):1131-9. PubMed ID: 12429791
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.
Foss HD; Anagnostopoulos I; Araujo I; Assaf C; Demel G; Kummer JA; Hummel M; Stein H
Blood; 1996 Nov; 88(10):4005-11. PubMed ID: 8916967
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.
Kamarashev J; Burg G; Mingari MC; Kempf W; Hofbauer G; Dummer R
Am J Pathol; 2001 May; 158(5):1593-8. PubMed ID: 11337356
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes.
Salhany KE; Macon WR; Choi JK; Elenitsas R; Lessin SR; Felgar RE; Wilson DM; Przybylski GK; Lister J; Wasik MA; Swerdlow SH
Am J Surg Pathol; 1998 Jul; 22(7):881-93. PubMed ID: 9669350
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic Molecule-positive Epstein-Barr Virus-associated Peripheral T-cell Lymphoma in a 20-Month-old Child: A Case Report and Review of the Literature.
Zhang H; Kheradpour A; Rowsell EH; Zuppan CW; Weiss LM; Wang J
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e475-80. PubMed ID: 26056791
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous EBV-positive γδ T-cell lymphoma vs. extranodal NK/T-cell lymphoma: a case report and literature review.
Yu WW; Hsieh PP; Chuang SS
J Cutan Pathol; 2013 Mar; 40(3):310-6. PubMed ID: 23240992
[TBL] [Abstract][Full Text] [Related]
18. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.
Cooke CB; Krenacs L; Stetler-Stevenson M; Greiner TC; Raffeld M; Kingma DW; Abruzzo L; Frantz C; Kaviani M; Jaffe ES
Blood; 1996 Dec; 88(11):4265-74. PubMed ID: 8943863
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
20. TCR-γ expression in primary cutaneous T-cell lymphomas.
Rodríguez-Pinilla SM; Ortiz-Romero PL; Monsalvez V; Tomás IE; Almagro M; Sevilla A; Camacho G; Longo MI; Pulpillo Á; Diaz-Pérez JA; Montes-Moreno S; Castro Y; Echevarría B; Trébol I; Gonzalez C; Sánchez L; Otín AP; Requena L; Rodríguez-Peralto JL; Cerroni L; Piris MÁ
Am J Surg Pathol; 2013 Mar; 37(3):375-84. PubMed ID: 23348211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]